Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2010 08:30 ET | Source: Tenax Therapeutics, Inc.

DERMACYTE(R) Skin Care Products Secure Major Listing on BeautyRiche.com, a Leading Dermatologic and Beauty E-Tail Web Site

DURHAM, N.C., Oct. 19, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced DERMACYTE® skin care products are now available for purchase...
October 13, 2010 10:31 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Enters Into Purchase Agreement to Sell $5 Million of Unsecured Promissory Notes to Vatea Fund

DURHAM, N.C., Oct. 13, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) entered into a Note Purchase Agreement with JP SPC 1 Vatea, Segregated Portfolio...
September 27, 2010 10:30 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Showcase New DERMACYTE(R) Oxygen-Enriched Lotions at Leading Spa and Resort Conference in New York City

DURHAM, N.C., Sept. 27, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) will showcase for the first time its DERMACYTE oxygen-rich skin care products at...
September 23, 2010 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Receives DSMB Approval to Proceed to the Next Cohort in Its Phase II-B Clinical Trial for Traumatic Brain Injury

DURHAM, N.C., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) reported today that the Data Safety Monitoring Board overseeing the company's...
September 20, 2010 02:00 ET | Source: Tenax Therapeutics, Inc.

U.S. Navy Broadens CRADA With Oxygen Biotherapeutics to Include Preclinical Studies Assessing Oxycyte(R) for Spinal Cord Injury Due to Decompression Sickness and for Hemorrhagic Shock

DURHAM, N.C., Sept. 20, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced it has amended an existing Cooperative Research and Development...
September 09, 2010 20:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports First Quarter FY2011 Financial Results

DURHAM, N.C., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
September 09, 2010 18:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Host Shareholder Presentation and Present at the 10th Annual Biotech Forum in Zurich, Switzerland

DURHAM, N.C., Sept. 9, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the Company will host a presentation to shareholders on...
September 07, 2010 20:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics TBI Study to be Offered to Injured Israeli Soldiers

DURHAM, N.C., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
September 03, 2010 18:52 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces First Quarter FY2011 Financial Results Conference Call and Webcast

DURHAM, N.C., Sept. 3, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
September 01, 2010 09:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Present at Rodman & Renshaw Conference in New York

DURHAM, N.C., Sept. 1, 2010 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that the company will present at the Rodman & Renshaw Annual Global...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right